{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:35:23Z","timestamp":1792017323329,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00018-015-1891-5","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T14:35:25Z","timestamp":1427898925000},"page":"3355-3373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells"],"prefix":"10.1007","volume":"72","author":[{"given":"Ana Bel\u00e9n","family":"Fern\u00e1ndez-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Lucio-Caza\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1464-410x.2000.00507.x","volume":"85","author":"AF Badawi","year":"2000","unstructured":"Badawi AF (2000) The role of prostaglandin synthesis in prostate cancer. BJU Int 85:451\u2013462","journal-title":"BJU Int"},{"key":"1891_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181\u2013193","journal-title":"Nat Rev Cancer"},{"key":"1891_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A (2009) The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377\u2013386","journal-title":"Carcinogenesis"},{"key":"1891_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.112.200444","volume":"344","author":"J Jiang","year":"2013","unstructured":"Jiang J, Dingledine R (2013) Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. J Pharmacol Exp Ther 344:360\u2013367","journal-title":"J Pharmacol Exp Ther"},{"key":"1891_CR5","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1158\/0008-5472.CAN-07-6689","volume":"68","author":"S Jain","year":"2008","unstructured":"Jain S, Chakraborty G, Raja R, Kale S, Kundu GC (2008) Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res 68:7750\u20137759","journal-title":"Cancer Res"},{"key":"1891_CR6","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/en.2012-2074","volume":"154","author":"BT Vo","year":"2013","unstructured":"Vo BT, Morton D, Komaragiri S, Millena AC, Leath C, Khan SA (2013) TGF-\u03b2 effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K\/AKT\/mTOR pathway. Endocrinology 154:1768\u20131779","journal-title":"Endocrinology"},{"key":"1891_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3835(02)00524-4","volume":"191","author":"T Hussain","year":"2003","unstructured":"Hussain T, Gupta S, Mukhtar H (2003) Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 191:125\u2013135","journal-title":"Cancer Lett"},{"key":"1891_CR8","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.peptides.2009.09.018","volume":"30","author":"AB Fern\u00e1ndez-Mart\u00ednez","year":"2009","unstructured":"Fern\u00e1ndez-Mart\u00ednez AB, Bajo AM, Valdehita A, Isabel Arenas M, S\u00e1nchez-Chapado M, Carmena MJ, Prieto JC (2009) Multifunctional role of VIP in prostate cancer progression in a xenograft model: suppression by curcumin and COX-2 inhibitor NS-398. Peptides 30:2357\u20132364","journal-title":"Peptides"},{"key":"1891_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2011.04.027","volume":"81","author":"Y Dai","year":"2011","unstructured":"Dai Y, Bae K, Siemann DW (2011) Impact of hypoxia on the metastatic potential of human prostate cancer cells. Int J Radiat Oncol Biol Phys 81:521\u2013528","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1891_CR10","doi-asserted-by":"crossref","first-page":"e54251","DOI":"10.1371\/journal.pone.0054251","volume":"8","author":"WK Ranasinghe","year":"2013","unstructured":"Ranasinghe WK, Xiao L, Kovac S, Chang M, Michiels C, Bolton D, Shulkes A, Baldwin GS, Patel O (2013) The role of hypoxia-inducible factor 1\u03b1 in determining the properties of castrate-resistant prostate cancers. PLoS One 8:e54251","journal-title":"PLoS One"},{"key":"1891_CR11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.2001.6188","volume":"290","author":"XH Liu","year":"2002","unstructured":"Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC (2002) Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6\/GP130\/STAT-3 signaling pathway. Biochem Biophys Res Commun 290:249\u2013255","journal-title":"Biochem Biophys Res Commun"},{"key":"1891_CR12","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.biocel.2012.08.015","volume":"44","author":"AB Fern\u00e1ndez-Mart\u00ednez","year":"2012","unstructured":"Fern\u00e1ndez-Mart\u00ednez AB, Jim\u00e9nez MI, Manzano VM, Lucio-Caza\u00f1a FJ (2012) Intracrine prostaglandin E(2) signalling regulates hypoxia-inducible factor-1\u03b1 expression through retinoic acid receptor-\u03b2. Int J Biochem Cell Biol 44:2185\u20132193","journal-title":"Int J Biochem Cell Biol"},{"key":"1891_CR13","first-page":"3150","volume":"9","author":"ST Palayoor","year":"2003","unstructured":"Palayoor ST, Tofilon PJ, Coleman CN (2003) Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin Cancer Res 9:3150\u20133157","journal-title":"Clin Cancer Res"},{"key":"1891_CR14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.biocel.2011.04.013","volume":"43","author":"AB Fern\u00e1ndez-Mart\u00ednez","year":"2011","unstructured":"Fern\u00e1ndez-Mart\u00ednez AB, Jim\u00e9nez MI, Hern\u00e1ndez IS, Garc\u00eda-Bermejo ML, Manzano VM, Fraile EA, de Lucio-Caza\u00f1a FJ (2011) Mutual regulation of hypoxic and retinoic acid related signalling in tubular proximal cells. Int J Biochem Cell Biol 43:1198\u20131207","journal-title":"Int J Biochem Cell Biol"},{"key":"1891_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1158\/1541-7786.MCR-12-0464","volume":"11","author":"HF Huang","year":"2013","unstructured":"Huang HF, Shu P, Murphy TF, Aisner S, Fitzhugh VA, Jordan ML (2013) Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer. Mol Cancer Res 11:427\u2013439","journal-title":"Mol Cancer Res"},{"key":"1891_CR16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mc.20320","volume":"46","author":"X Wang","year":"2007","unstructured":"Wang X, Klein RD (2007) Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Mol Carcinog 46:912\u2013923","journal-title":"Mol Carcinog"},{"key":"1891_CR17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biocel.2014.11.004","volume":"59","author":"A Madrigal","year":"2015","unstructured":"Madrigal A, Lucio Caza\u00f1a FJ, Fern\u00e1ndez-Mart\u00ednez AB (2015) Intracellular Prostaglandin E2 strengthens cancer-related phenotypes in PC3 cells. Int J Biochem Cell Biol 59:52\u201361","journal-title":"Int J Biochem Cell Biol"},{"key":"1891_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biocel.2009.09.015","volume":"42","author":"DF Legler","year":"2010","unstructured":"Legler DF, Bruckner M, Uetz-von Allmen E, Krause P (2010) Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 42:198\u2013201","journal-title":"Int J Biochem Cell Biol"},{"key":"1891_CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0090-6980(02)00061-8","volume":"68\u201369","author":"VL Schuster","year":"2002","unstructured":"Schuster VL (2002) Prostaglandin transport. Prostaglandins Other Lipid Mediat 68\u201369:633\u2013647","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1891_CR20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.7754369","volume":"268","author":"N Kanai","year":"1995","unstructured":"Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL (1995) Identification and characterization of a prostaglandin transporter. Science 268:866\u2013869","journal-title":"Science"},{"key":"1891_CR21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI118897","volume":"98","author":"R Lu","year":"1996","unstructured":"Lu R, Kanai N, Bao Y, Schuster VL (1996) Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest 98:1142\u20131149","journal-title":"J Clin Invest"},{"key":"1891_CR22","doi-asserted-by":"crossref","first-page":"F1103","DOI":"10.1152\/ajprenal.00152.2001","volume":"282","author":"Y Bao","year":"2002","unstructured":"Bao Y, Pucci ML, Chan BS, Lu R, Ito S, Schuster VL (2002) Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. Am J Physiol Renal Physiol 282:F1103\u2013F1110","journal-title":"Am J Physiol Renal Physiol"},{"key":"1891_CR23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/mol.65.4.973","volume":"65","author":"T Nomura","year":"2004","unstructured":"Nomura T, Lu R, Pucci ML, Schuster VL (2004) The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol 65:973\u2013978","journal-title":"Mol Pharmacol"},{"key":"1891_CR24","doi-asserted-by":"crossref","first-page":"15792","DOI":"10.1073\/pnas.95.26.15792","volume":"95","author":"M Bhattacharya","year":"1998","unstructured":"Bhattacharya M, Peri KG, Almazan G, Ribeiro-da-Silva A, Shichi H, Durocher Y, Abramovitz M, Hou X, Varma DR, Chemtob S (1998) Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci USA 95:15792\u201315797","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR25","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1074\/jbc.274.22.15719","volume":"274","author":"M Bhattacharya","year":"1999","unstructured":"Bhattacharya M, Peri K, Ribeiro-da-Silva A, Almazan G, Shichi H, Hou X, Varma DR, Chemtob S (1999) Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 274:15719\u201315724","journal-title":"J Biol Chem"},{"key":"1891_CR26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/cdd.2010.128","volume":"18","author":"L Lalier","year":"2011","unstructured":"Lalier L, Cartron PF, Olivier C, Log\u00e9 C, Bougras G, Robert JM, Oliver L, Vallette FM (2011) Prostaglandins antagonistically control Bax activation during apoptosis. Cell Death Differ 18:528\u2013537","journal-title":"Cell Death Differ"},{"key":"1891_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-11-153","volume":"11","author":"L Lalier","year":"2011","unstructured":"Lalier L, Pedelaborde F, Braud C, Menanteau J, Vallette FM, Olivier C (2011) Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell. BMC Cancer 11:153","journal-title":"BMC Cancer"},{"key":"1891_CR28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.RES.0000013303.17964.7A","volume":"90","author":"F Gobeil","year":"2002","unstructured":"Gobeil F, Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, Abran D, Hou X, Beauchamp MH, Quiniou C, Bouayad A, Choufani S, Bhattacharya M, Molotchnikoff S, Ribeiro-Da-Silva A, Varma DR, Bkaily G, Chemtob S (2002) Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ Res 90:682\u2013689","journal-title":"Circ Res"},{"key":"1891_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1139\/y05-147","volume":"84","author":"T Zhu","year":"2006","unstructured":"Zhu T, Gobeil F, Vazquez-Tello A, Leduc M, Rihakova L, Bossolasco M, Bkaily G, Peri K, Varma DR, Orvoine R, Chemtob S (2006) Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. Can J Physiol Pharmacol 84:377\u2013391","journal-title":"Can J Physiol Pharmacol"},{"key":"1891_CR30","first-page":"2029","volume":"2013","author":"AB Fern\u00e1ndez-Mart\u00ednez","year":"1833","unstructured":"Fern\u00e1ndez-Mart\u00ednez AB, Lucio Caza\u00f1a FJ (1833) Epidermal growth factor receptor transactivation by intracellular prostaglandin E2-activated prostaglandin E2 receptors. Role in retinoic acid receptor-\u03b2 up-regulation. Biochim Biophys Acta 2013:2029\u20132038","journal-title":"Biochim Biophys Acta"},{"key":"1891_CR31","first-page":"1997","volume":"2014","author":"AB Fern\u00e1ndez-Mart\u00ednez","year":"1843","unstructured":"Fern\u00e1ndez-Mart\u00ednez AB, Lucio Caza\u00f1a FJ (1843) Prostaglandin E2 induces retinoic acid receptor-\u03b2 up-regulation through MSK1. Biochim Biophys Acta 2014:1997\u20132004","journal-title":"Biochim Biophys Acta"},{"key":"1891_CR32","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1038\/sj.onc.1210303","volume":"26","author":"L Lalier","year":"2007","unstructured":"Lalier L, Cartron PF, Pedelaborde F, Olivier C, Loussouarn D, Martin SA, Meflah K, Menanteau J, Vallette FM (2007) Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients\u2019 survival in glioblastoma multiforme. Oncogene 26:4999\u20135009","journal-title":"Oncogene"},{"key":"1891_CR33","doi-asserted-by":"crossref","unstructured":"Rasmuson A, Kock A, Fuskev\u00e5g OM, et al (2012) Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma. Castresana JS. PLoS One 7:e29331","DOI":"10.1371\/journal.pone.0029331"},{"key":"1891_CR34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.urology.2006.09.035","volume":"68","author":"Y Miyata","year":"2006","unstructured":"Miyata Y, Kanda S, Maruta S, Matsuo T, Sakai H, Hayashi T, Kanetake H (2006) Relationship between prostaglandin E2 receptors and clinicopathologic features in human prostate cancer tissue. Urology 68:1360\u20131365","journal-title":"Urology"},{"key":"1891_CR35","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1074\/jbc.M006180200","volume":"276","author":"J Aragon\u00e9s","year":"2001","unstructured":"Aragon\u00e9s J, Jones DR, Martin S, San Juan MA, Alfranca A, Vidal F, Vara A, M\u00e9rida I, Land\u00e1zuri MO (2001) Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension. J Biol Chem 276:10548\u201310555","journal-title":"J Biol Chem"},{"key":"1891_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0092-8674(00)81863-2","volume":"88","author":"T Krude","year":"1997","unstructured":"Krude T, Jackman M, Pines J, Laskey RA (1997) Cyclin\/Cdk dependent initiation of DNA replication in a human cell-free system. Cell 88:109\u2013119","journal-title":"Cell"},{"key":"1891_CR37","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1083\/jcb.97.5.1648","volume":"97","author":"R Montesano","year":"1983","unstructured":"Montesano R, Orci L, Vassalli P (1983) In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97:1648\u20131652","journal-title":"J Cell Biol"},{"key":"1891_CR38","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604\u20134613","journal-title":"Mol Cell Biol"},{"key":"1891_CR39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","volume":"295","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:858\u2013861","journal-title":"Science"},{"key":"1891_CR40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrc2174","volume":"7","author":"SJ Ellem","year":"2007","unstructured":"Ellem SJ, Risbridger GP (2007) Treating prostate cancer: a rationale for targeting local oestrogens. Nat Rev Cancer 7:621\u2013627","journal-title":"Nat Rev Cancer"},{"key":"1891_CR41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgh317","volume":"26","author":"GS Palapattu","year":"2005","unstructured":"Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, Nelson WG (2005) Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26:1170\u20131181","journal-title":"Carcinogenesis"},{"key":"1891_CR42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcb.10747","volume":"91","author":"AM Marzo De","year":"2004","unstructured":"De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB, Nelson WG (2004) Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 91:459\u2013477","journal-title":"J Cell Biochem"},{"key":"1891_CR43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","volume":"349","author":"WG Nelson","year":"2003","unstructured":"Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349:366\u2013381","journal-title":"N Engl J Med"},{"key":"1891_CR44","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/01.ju.0000108131.43160.77","volume":"171","author":"EA Platz","year":"2004","unstructured":"Platz EA, De Marzo AM (2004) Epidemiology of inflammation and prostate cancer. J Urol 171:S36\u2013S40","journal-title":"J Urol"},{"key":"1891_CR45","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.ju.0000108142.53241.47","volume":"171","author":"MS Lucia","year":"2004","unstructured":"Lucia MS, Torkko KC (2004) Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale. J Urol 171:S30\u2013S34 (discussion S35)","journal-title":"J Urol"},{"key":"1891_CR46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1158\/1940-6207.CAPR-07-0009","volume":"1","author":"VR Holla","year":"2008","unstructured":"Holla VR, Backlund MG, Yang P, Newman RA, DuBois RN (2008) Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Phila) 1:93\u201399","journal-title":"Cancer Prev Res (Phila)"},{"key":"1891_CR47","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/bjc.2012.430","volume":"107","author":"HJ Smartt","year":"2012","unstructured":"Smartt HJ, Greenhough A, Ord\u00f3\u00f1ez-Mor\u00e1n P, Al-Kharusi M, Collard TJ, Mariadason JM, Huelsken J, Williams AC, Paraskeva C (2012) \u03b2-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin? Br J Cancer 107:1514\u20131517","journal-title":"Br J Cancer"},{"key":"1891_CR48","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282:11613\u201311617","journal-title":"J Biol Chem"},{"key":"1891_CR49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-6147(03)00162-7","volume":"24","author":"H Fujino","year":"2003","unstructured":"Fujino H, Regan JW (2003) Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol Sci 24:335\u2013340","journal-title":"Trends Pharmacol Sci"},{"key":"1891_CR50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lfs.2003.09.031","volume":"74","author":"JW Regan","year":"2003","unstructured":"Regan JW (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci 74:143\u2013153","journal-title":"Life Sci"},{"key":"1891_CR51","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Mart\u00ednez AB, Lucio Caza\u00f1a FJ (2014) Transactivation of EGFR by Prostaglandin E2 receptors: a nuclear story? CMLS. (In press)","DOI":"10.1007\/s00018-014-1802-1"},{"key":"1891_CR52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.mce.2010.04.008","volume":"331","author":"C Liebmann","year":"2011","unstructured":"Liebmann C (2011) EGF receptor activation by GPCRs: an universal pathway reveals different versions. Mol Cell Endocrinol 331:222\u2013231","journal-title":"Mol Cell Endocrinol"},{"key":"1891_CR53","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1042\/bst0311203","volume":"31","author":"OM Fischer","year":"2003","unstructured":"Fischer OM, Hart S, Gschwind A, Ullrich A (2003) EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203\u20131208","journal-title":"Biochem Soc Trans"},{"key":"1891_CR54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm1173","volume":"4","author":"R Wetzker","year":"2003","unstructured":"Wetzker R, B\u00f6hmer FD (2003) Transactivation joins multiple tracks to the ERK\/MAPK cascade. Nat Rev Mol Cell Biol 4:651\u2013657","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1891_CR55","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/sj.onc.1204192","volume":"20","author":"A Gschwind","year":"2001","unstructured":"Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A (2001) Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20:1594\u20131600","journal-title":"Oncogene"},{"key":"1891_CR56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plefa.2003.04.005","volume":"70","author":"RJ Helliwell","year":"2004","unstructured":"Helliwell RJ, Berry EB, O\u2019Carroll SJ, Mitchell MD (2004) Nuclear prostaglandin receptors: role in pregnancy and parturition? Prostaglandins LeukotEssent Fatty Acids 70:149\u2013165","journal-title":"Prostaglandins LeukotEssent Fatty Acids"},{"key":"1891_CR57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2012.01.011","volume":"318","author":"W Han","year":"2012","unstructured":"Han W, Lo HW (2012) Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations. Cancer Lett 318:124\u2013134","journal-title":"Cancer Lett"},{"key":"1891_CR58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/pcan.2013.53","volume":"17","author":"E Kashiwagi","year":"2014","unstructured":"Kashiwagi E, Shiota M, Yokomizo A, Inokuchi J, Uchiumi T, Naito S (2014) EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer. Prostate Cancer Prostatic Dis 17:10\u201317","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1891_CR59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","volume":"34","author":"J Jiang","year":"2013","unstructured":"Jiang J, Dingledine R (2013) Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection. Trends Pharmacol Sci 34:413\u2013423","journal-title":"Trends Pharmacol Sci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-015-1891-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-015-1891-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T18:29:11Z","timestamp":1566498551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-015-1891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":59,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1007\/s00018-015-1891-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}